Connect your AI

Seaport Therapeutics SPTX Depreciation

Depreciation at other companies

TransDigm GroupTDG

$44M+7.3%

Bloom EnergyBE

$13.28M+10.8%

Comfort Systems USAFIX

$18.57M+32.5%

Illinois Tool WorksITW

$81M+9.5%

Lumentum Holdings Inc.LITE

$32.8M+31.2%

CintasCTAS

$80.15M+4.9%

Other financials

Income statement

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Seaport Therapeutics 's depreciation?: Seaport Therapeutics (SPTX) reported depreciation of $26K in Q1 2026.